CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS PRODUCT LICENSE AND ASSIGNMENT AGREEMENT Dated as of October 11, 2006 By and Among CYTOGEN CORPORATION (a Delaware...Product License and Assignment Agreement • November 9th, 2006 • Cytogen Corp • Pharmaceutical preparations • New York
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS AMENDMENT NO. 1 TO PRODUCT LICENSE AND ASSIGNMENT AGREEMENTProduct License and Assignment Agreement • November 14th, 2007 • Cytogen Corp • Pharmaceutical preparations
This Amendment No. 1 to that certain Product License and Assignment Agreement (this “Amendment”) is made and entered into as of August 30, 2007 by and among CYTOGEN CORPORATION, a Delaware corporation having an address at 650 College Road East, Suite 3100, Princeton, New Jersey 08540, United States (“Cytogen”), INPHARMA AS, a Norwegian company having an address at Pb 2030 (Konnerudgt. 27), 3003 Drammen, Norway (“Inpharma Norway”), and INPHARMA, INC., a Delaware corporation having an address at 101 Federal Street, Suite 1900, Boston, Massachusetts 02110 (“Inpharma USA,” together with Inpharma Norway, “Inpharma”).
AMENDMENT NO. 2 TO PRODUCT LICENSE AND ASSIGNMENT AGREEMENTProduct License and Assignment Agreement • May 8th, 2008 • Cytogen Corp • Pharmaceutical preparations
This Amendment No. 2 to that certain Product License and Assignment Agreement (this “Amendment”) is made and entered into as of February 14, 2008 by and between CYTOGEN CORPORATION, a Delaware corporation having an address at 650 College Road East, Suite 3100, Princeton, New Jersey 08540, United States (“Cytogen”), and INPHARMA AS, a Norwegian company having an address at Pb 2030 (Konnerudgt. 27), 3003 Drammen, Norway (“Inpharma”).
